Physician

Paul D Weishaar, M.D.

According to 2025 Medicare claims, Paul Weishaar, M.D. (NPI: 1548261696) practices ophthalmology in the Wichita, KS market, with the plurality of this provider's patient population coming from Sedgwick, KS. This provider's primary affiliated billing organization is VITREO-RETINAL CONSULTANTS & SURGEONS PA (NPI: 1275557761; TIN: 48-0817150) and primary practice location at 67214-4837. Weishaar is affiliated with the Aledade 149 Regional MSSP (ACO ID: A5231), participating under the MSSP model.

Weishaar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,138 traditional Medicare patients, billed 65,143 HCPCS/CPT codes, and received $3,349,937 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,188 prescription claims across 339 beneficiaries totaling $36,609 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 44 records totaling $1,692. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $55,552 to $36,609. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,828	17,716	$3,348,594
2016	1,974	20,032	$3,874,030
2017	1,846	21,287	$4,173,903
2018	1,778	20,889	$3,686,924
2019	1,795	19,495	$3,807,128
2020	1,555	16,603	$3,185,121
2021	1,584	18,712	$3,940,604
2022	1,538	29,446	$4,082,275
2023	1,337	58,626	$3,533,739
2024	1,138	65,143	$3,349,937

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	303	1,035	$55,552
2016	328	1,161	$58,288
2017	339	1,261	$56,062
2018	307	1,192	$436,710
2019	318	1,153	$52,642
2020	299	1,192	$53,230
2021	313	1,169	$48,853
2022	314	1,211	$50,744
2023	314	1,171	$43,476
2024	339	1,188	$36,609

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	375	505	$86
67028	Injection of drug into eye	479	1,672	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	703	1,087	$58
J2777	Injection, faricimab-svoa, 0.1 mg	203	53,100	$27
92134	Imaging of retina	907	2,527	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	260	7,515	$7,354
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	199	14,067	$3,009
Latanoprost	Latanoprost	430	16,864	$2,327
Simbrinza	Brinzolamide/Brimonidine Tart	11	416	$2,132
Brimonidine Tartrate	Brimonidine Tartrate	46	1,619	$1,003

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$1,692	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$28,668	US Retina LLC

Explore More Providers

FAQ

What Medicare data is available for Paul D. Weishaar, M.D.?

Tedicare shows public-source Medicare data for Paul D. Weishaar, M.D. (NPI 1548261696), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul D. Weishaar, M.D. have ACO affiliation data?

Paul D. Weishaar, M.D. is shown with ACO affiliation data for Aledade 149 Regional MSSP (MSSP, ACO ID A5231).

What billing organization is linked to Paul D. Weishaar, M.D.?

Paul D. Weishaar, M.D. is linked to VITREO-RETINAL CONSULTANTS & SURGEONS PA (billing NPI 1275557761) in the available physician profile data.

Does Paul D. Weishaar, M.D. have Open Payments data?

Paul D. Weishaar, M.D. has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.